Research examines calixarenes as drug delivery agents for chronic myeloid leukemia therapies, suggesting efficacy.
Today, on the last day of 2015, we have received great news that our latest paper regarding thr study of calixarenes as drug delivery agents has been published in the Journal of computational chemistry (10.1002/jcc.24281) This work represents the continuation of our previous paper published last year in JCTC regarding the use of delivery agents for drugs used in the treatment of chronic myeloid leukemia;
No takes yet. Share an insight, caveat, or question.
José G. Barroso (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: